Latest Kommanditgesellschaft auf Aktien Stories
- Merck KGaA, Darmstadt, Germany is a leading company in the growing market of fertility technologies to support standardization and improve fertility outcomes ROCKLAND, Mass., May 28, 2015
- Acquiring exclusive worldwide rights to Singulex's SMC(TM) technology - instruments, assays and services - for research applications BILLERICA, Mass., May 21, 2015 /PRNewswire/
- Reicin brings extensive experience in R&D as a senior leader in biopharma ROCKLAND, Mass., April 16, 2015 /PRNewswire/ -- EMD Serono today announced the US biopharmaceutical
ROCKLAND, Mass., April 6, 2015 /PRNewswire/ -- EMD Serono, the U.S.
- Experienced leader and expert clinician to deliver strong outcomes for patients in the areas of Neurology and Immunology ROCKLAND, Mass., April 1, 2015 /PRNewswire/ -- EMD
- Chimeric Antigen Receptor T-cell (CAR-T) therapy enhances R&D technology portfolio of Merck KGaA, Darmstadt, Germany, in immuno-oncology DARMSTADT, Germany, March 30, 2015 /PRNewswire/
-- Collaboration strengthens company's position as a leader in precision medicine in oncology ROCKLAND, Mass., March 10, 2015 /PRNewswire/ -- EMD Serono today announced that the biopharmaceutical
- Personalized immunotherapy Tcelna (imilecleucel-T), an investigational compound currently in a Phase IIb clinical study in patients with secondary progressive multiple sclerosis (SPMS), an area of
- EMD Millipore services include design and development of cost-effective process to deliver high yield and productivity DARMSTADT, Germany, Feb.
- New AFS® 40E / 80E / 120E and 150E systems fulfill pure water needs for one or several high-throughput clinical analyzers DARMSTADT, Germany, Jan.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.